Category: News
09 July 2021
Urine biomarkers for treatment response
Considerable unmet biomarker potential exists in the treatment of bladder cancer By Dr. Patrick Hensley (Houston, US) & Dr. Ashish M. Kamat (Houston,
09 July 2021
Antimicrobial resistance: How to deal with the pandemic
By Dr. José Medina-Polo (Madrid, ES), Associate Member of the ESIU This article reflects the highlights of the lecture Dr. José Medina-Polo
09 July 2021
Insightful and eye-opening presentations at first-ever EAU Patient Day
Today was the birth of the very first EAU Patient Day at the Annual EAU Congress. On the second day
08 July 2021
Welcome to the 36th Annual EAU Congress
08 July 2021
Urology beyond Europe: Different approaches, same goal
The mission of the European Association of Urology (EAU) is to raise the level of urological care throughout Europe and
08 July 2021
Report: Semi-live surgery session also weighs up educational value and future potential
“Technology development never ends!” was the catch-all title for the nearly eight-hour flagship semi-live surgical session at EAU21, and it
08 July 2021
Incontinence mesh removal surgery in women
By Dr. Marie-Aimée Perrouin-Verbe (Nantes, FR), Department of Urology, Nantes Academic Hospital & Prof. Hashim Hashim (Bristol, GB), Bristol Urological Institute, Southmead Hospital This
08 July 2021
Using pharmacotherapy for OAB: What drug interactions to be aware of
By Prof. Martin C. Michel (Mainz, DE), Department of Pharmacology, Johannes Gutenberg University This article reflects the highlights of the lecture Prof.
08 July 2021
EAU21 opens with full-day semi-live surgery and Urology Beyond Europe sessions
EAU Secretary General Prof. Chris Chapple welcomed delegates to the 36th Annual EAU Congress, EAU21. Speaking from a studio in
07 July 2021
The PIONEER Big Data platform: How does it apply to prostate cancer?
By Dr. Susan Evans Axelsson (Malmö, SE), Clinical Coordinator PIONEER This article reflects the highlights of the lecture Dr. Susan Evans Axelsson
06 July 2021
RPLND for chemo-resistant disease: Examining different options for different patients
By Prof. Axel Heidenreich (Cologne, DE), Department of Urology, University Hospital Cologne This article reflects the highlights of the lecture Prof.
05 July 2021
Immunotherapy for metastatic urothelial cancer
New agents are expected to significantly improve overall prognosis By Dr. Ursula Vogl (Bellinzona, CH), medical oncologist at Ospedale San Giovanni
05 July 2021